The New Zealand government has announced an agreement with pharmaceutical giant Pfizer for the supply of COVID-19 vaccine doses. This agreement will provide the country with enough doses to vaccinate its entire population.
The agreement comes after a long negotiation process between Pfizer and the New Zealand government. The government had been in talks with several other vaccine manufacturers, but ultimately decided to go with Pfizer due to its high efficacy rate and strong safety profile.
Under the terms of the agreement, Pfizer will deliver 1.5 million doses of its vaccine to New Zealand by the end of July. The remaining doses will be delivered throughout the year, with the aim of vaccinating everyone in the country by the end of 2021.
New Zealand`s Prime Minister, Jacinda Ardern, hailed the agreement as a “significant step forward” in the country`s fight against COVID-19. She also praised Pfizer for its transparency and cooperation throughout the negotiation process.
The Pfizer vaccine has already been approved for use in New Zealand by the country`s regulatory agency, Medsafe. The vaccine has been shown to be highly effective in preventing COVID-19, with clinical trials showing an efficacy rate of over 90%.
The New Zealand government has stated that the vaccine will be provided free of charge to all citizens and residents, and that it will be distributed in a phased rollout based on priority groups such as healthcare workers, the elderly, and those with underlying health conditions.
Overall, the agreement between New Zealand and Pfizer is a significant development in the global fight against COVID-19. It provides hope for the millions of people around the world who are still waiting for access to a vaccine, and it represents a major milestone in New Zealand`s efforts to keep its citizens safe and healthy.